绵羊多羔主效基因BMPR1B的研究进展

骨形态发生蛋白受体1B(Bone morphogenetic protein receptor 1B,BMPR1B)是一种重要的跨膜受体蛋白,主要参与转化生长因子β(TGF-β)通路,其在调控成骨分化、细胞扩散以及卵巢卵泡发育等过程中起重要作用,并直接影响如绵羊等动物的繁殖性状。绵羊BMPR1B基因发生A746G突变(命名为FecB突变),导致第249位氨基酸由谷氨酰胺(Q)转变为精氨酸(R),进而使得绵羊排卵数和产羔数显著增加,因此BMPR1B成为目前最受关注的绵羊多羔主效基因。论文就绵羊BMPR1B基因定位、功能机制研究进展及其对高繁殖力绵羊的影响进行了综述,同时也对BMPR1B功能研究中一些亟待解决的问题展开了讨论。     

Changes in blood profile in sheep receiving raw garlic,garlic oil or monensin

This study aimed to evaluate the effects of supplementing a basal diet (CTR) with raw garlic (GAR) or garlic oil (GAO) on blood profile in sheep. Monensin (MON, 33 mg/kg DM) was used as positive control. Four ruminally fistulated rams were used in three experiments each arranged in a 4 × 4 Latin square design with 28‐day periods. Experiments 1 and 2 differed in the dose of GAR (75 vs. 100 g/kg DM) and GAO (500 vs. 750 mg/kg DM), while experiment 3 was designed to compare the two doses of each additive (GAR and GAO). The animals were fed a basal diet as TMR consisting of 77.83% forage (alfalfa hay and corn silage) and 22.17% concentrate, providing 10.50 MJ/kg DM (metabolizable energy) and 16.5% crude protein to cover maintenance energy and protein requirements. Supplementation of monensin decreased (P < 0.05) β‐hydroxybutyrate (BHB) and non‐esterified fatty acid (NEFA) concentrations in the blood compared with other treatments. There was no significant effect of additives on serum concentration of glucose, total triglycerides, cholesterol, total protein, albumin and blood urea nitrogen (BUN). Although the serum insulin concentration was elevated in sheep receiving MON and GAO (P < 0.01), no change was observed in blood glucose concentration. No significant effect of GAO and GAR was observed in key energy and protein‐related blood metabolites. However, administration of monensin had a positive influence on energy indices. In conclusion, whereas parameters characterizing the energy balance did not show a significant effect of GAR supplementation, a higher insulin concentration in GAO‐treated animals was observed.     

PMSG对甘肃高山细毛羊同期发情和繁殖率的影响

在甘肃省肃南县康乐乡对甘肃高山细毛羊应用阴道栓与孕马血清促性腺激素(PMSG)结合处理,结果表明,不同注射剂量和处理方式对母羊的同期发情和繁殖率均有影响,在埋栓后12.5 d注射550 IU PMSG并在放栓后14 d撤除阴道栓后的0-48 h发情率显著高于其他试验组(P0.05);在埋栓后13 d注射600 IU PMSG同时撤除阴道栓的试验组繁殖率最高(P0.05)。但综合繁殖率和经济效益考虑,在埋栓后间隔12.5 d注射550 IU PMSG并在放栓后14 d撤除阴道栓0-48 h的试验组效果最好,平均每只母羊净收入可达773.7元。     

不同代谢葡萄糖水平对绵羊人工瘤胃发酵特性、微生物蛋白质浓度和产气参数的影响

本试验旨在通过人工瘤胃体外培养,研究不同代谢葡萄糖水平下的绵羊瘤胃发酵特性、微生物蛋白质浓度和产气参数。采用单因子试验设计,共设计4个代谢葡萄糖水平[125(A)、138(B)、153(C)、168 g/kg(D)]。体外试验所用瘤胃液采自4只安装有永久性瘤胃瘘管的绵羊。分别于培养0、2、4、6、8、12、24 h采集2 mL培养液用于分析。结果表明:1)8~24 h培养液pH随着代谢葡萄糖水平的提高而出现显著或极显著下降(P0.05或P0.01);氨氮浓度在2 h时D组显著高于A组(P0.05),而在6 h时A组显著高于其他3组(P0.05)。2)D组6h培养液细菌蛋白浓度显著高于A组(P0.05);随着代谢葡萄糖水平的提高,培养液丙酸、丁酸、总挥发性脂肪酸的浓度总体呈升高趋势,乙酸/丙酸呈下降趋势。3)随着代谢葡萄糖水平的提高,理论最大产气量极显著降低(P0.01),达1/2理论最大产气量的时间极显著缩短(P0.01);潜在产气量无显著变化(P0.05),24 h产气量和产气速率常数分别显著或极显著下降和上升(P0.05或P0.01)。结果提示,提高代谢葡萄糖水平,可以提高丙酸、总挥发性脂肪酸的浓度,同时可为绵羊提供较多的生糖前体物质。     

小麦饲料中添加木聚糖酶对高原型藏羊胃肠道发育的影响

旨在分析小麦粉中添加木聚糖酶(xylanase, Xyl)对藏羊羔羊胃肠道发育的影响。选择同质性良好的2～3月龄高原型藏羊公羔60只,随机分为两组,每组30只,各组内设置5个重复。对照组(Control group)饲喂不含木聚糖酶的日粮,试验组(Test group)饲喂含0.2%木聚糖酶的日粮,试验分为预饲期10 d和正试期90 d。饲养试验结束时,两组各随机选取5只羔羊进行屠宰,采集消化道组织置于多聚甲醛固定,并收集血液、瘤胃和空肠内容物。结果显示：1)与对照组相比,试验组瘤胃的角质层厚度、颗粒层厚度,瓣胃的乳头长度、乳头宽度、角质层厚度、颗粒层厚度,皱胃的黏膜厚度以及十二指肠的肌层厚度,空肠的绒毛高度、黏膜厚度,回肠的肌层厚度显著提高(P<0.05);2)对照组瘤胃和血清的LPS含量显著高于试验组(P<0.05);3)相较于对照组,试验组瘤胃的糜蛋白酶、胰蛋白酶、脂肪酶活性以及空肠的糜蛋白酶、α-淀粉酶活性显著提高(P<0.05);4)试验组瘤胃的总抗氧化能力水平、谷胱甘肽过氧化物酶及过氧化氢酶活性以及空肠的总抗氧化能力水平、谷胱甘肽过氧化物酶、超氧化物歧化酶...     

棕榈粕替代部分玉米对藏羊母羊小肠形态发育、消化酶活性及抗氧化功能的影响

试验旨在探究精料补充料中使用不同比例棕榈粕替代玉米对藏羊母羊肠道组织形态学、消化酶活性、pH、脂多糖以及抗氧化能力的影响。选取初始体重相近且健康的2～3月龄高原型藏羊母羊120只,随机分为4组,每组30只,每组6个重复,每个重复5只母羊,分别饲喂0%、15%、18%和21%水平的棕榈粕替代精料中玉米。试验期97d。结果显示：1)0%组与15%组间小肠各段的绒毛高度、绒毛宽度、隐窝深度、黏膜厚度以及绒毛高度/隐窝深度差异均不显著（P>0.05）;2)0%组空肠的α-淀粉酶、纤维素酶、脂肪酶及糜蛋白酶显著或极显著小于15%组（P<0.05或P<0.01）;3)0%组空肠的谷胱甘肽过氧化物酶、过氧化氢酶活性显著低于15%组与18%组（P<0.05）,相较于21%组差异不显著（P>0.05）;4)18%组与21%组空肠的脂多糖含量显著或极显著高于0%组（P<0.05或P<0.01）,与15%组相比差异不显著（P>0.05）。由此可见,棕榈粕可替代部分玉米饲喂藏羊母羊,推荐替代玉米的比例为15%。     

Assessment of the long‐acting ivermectin formulation in sheep: Further insight into potential pharmacokinetic interactions

The aim of the current study was to evaluate the in vivo pharmacokinetic of ivermectin (IVM) after the administration of a long‐acting (LA) formulation to sheep and its impact on potential drug‐drug interactions. The work included the evaluation of the comparative plasma profiles of IVM administered at a single therapeutic dose (200 μg/kg) and as LA formulation at 630 μg/kg. Additionally, IVM was measured in different gastrointestinal tissues at 15 days posttreatment with both IVM formulations. The impact of the long‐lasting and enhanced IVM exposure on the disposition kinetics of abamectin (ABM) was also assessed. Plasma (IVM and ABM) and gastrointestinal (IVM) concentrations were analyzed by HPLC with fluorescent detection. In plasma, the calculated C_max and AUC_0‐t values of the IVM‐LA formulation were 1.47‐ and 3.35‐fold higher compared with IVM 1% formulation, respectively. The T_1/2ab and T_max collected after administration of the LA formulation were 2‐ and 3.5‐fold longer than those observed after administration of IVM 1% formulation, respectively. Significantly higher IVM concentrations were measured in the intestine mucosal tissues and luminal contents with the LA formulation, and in the liver, the increase was 7‐fold higher than conventional formulation. There was no drug interaction between IVM and ABM after the single administration of ABM at 15 days post‐administration of the IVM LA formulation. The characterization of the kinetic behavior of the LA formulation to sheep and its potential influence on drug‐drug interactions is a further contribution to the field.